Lyophilisation is crucial in the creation of pharmaceutical ingredients with an extended shelf life, however, current methods can still be costly and time consuming. Hosokawa Micron reveals its new method of contained active freeze drying as a potential solution.
Hosokawa Micron
In the pharmaceutical industry the necessity of freeze drying (lyophilisation) is well known. Through removal of water, a product’s shelf life can be extended, with the added benefit of making storage and shipping easier. Additionally, in the case of active pharmaceutical ingredients (APIs), lyophilisation can ensure chemical stability at room temperature. In these instances, freeze drying is performed using trays.1,2